Stocks
Intellia Therapeutics, Inc.NTLA
NASDAQHealthcareBiotechnology$12.76-0.70%
A clinical-stage biotechnology company developing CRISPR-based gene editing therapies designed to treat genetic diseases. Its pipeline focuses on in vivo genome editing programs, including treatments for transthyretin amyloidosis and other rare disorders, with key collaborations such as its partners...
Market Cap: $1.5B52W Range: $5.90 – $28.25
This page tracks all publicly disclosed congressional trades in Intellia Therapeutics, Inc. (NTLA), a company in the Healthcare sector. 4 members of Congress have disclosed trades in this stock, including 7 purchases and 8 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
15
Unique Politicians
4
Buys
7
Sells
8
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-08-25 | Thomas R Carper | sell | $1K – $15K |
| 2023-05-22 | Thomas R Carper | buy | $1K – $15K |